Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · IEX Real-Time Price · USD
0.418
+0.023 (5.82%)
At close: Jul 26, 2024, 10:23 AM
0.415
-0.003 (-0.72%)
After-hours: Jul 26, 2024, 4:23 PM EDT
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $3.07 million as of July 26, 2024. Its market cap has decreased by -75.01% in one year.
Market Cap
3.07M
Enterprise Value
1.08M
1-Year Change
-75.01%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $3.07M, a decrease of -90.61%. That is a compound annual growth rate of -77.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 3.10M | -47.46% |
| Dec 29, 2023 | 5.90M | -66.85% |
| Dec 30, 2022 | 17.80M | -45.63% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akanda | 3.14M |
| Aptevo Therapeutics | 3.14M |
| Ensysce Biosciences | 3.13M |
| Alzamend Neuro | 3.10M |
| Xylo Technologies | 3.04M |
| Petros Pharmaceuticals | 2.98M |
| Qualigen Therapeutics | 2.88M |
| TC Biopharm (Holdings) | 2.85M |